Contact this trialFirst, we need to learn more about you.
CDK4/6 Inhibitor
Abemaciclib + Bicalutamide for Breast Cancer
Recruiting3 awardsPhase 1 & 2
New York, New York
This trial is testing a new drug, abemaciclib, in combination with bicalutamide for treating metastatic breast cancer that is positive for the androgen receptor and negative for HER2.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.